Krystal Biotech KRYS reported first-quarter 2026 earnings per share (EPS) of $1.83, which surpassed the Zacks Consensus Estimate of $1.45. The reported EPS was up from $1.20 in the year-ago quarter.

CEO Hilton Schlosberg opened the call highlighting another quarter of record results, stating, "We're pleased to report yet another quarter of strong financial results and cash generation with record ...

Have you ever received an email urging you to buy items you left in your cart? This is a strategy businesses use to advance you through the sales pipeline. A sales pipeline breaks down each stage of a ...

Robert Michael, CEO & Chairman of the Board, reported "record net sales and exceeded our financial commitments, advanced our pipeline across all stages of development and acquired new sources of ...